newdrugapprovals.org
FDA accepts Merck BLA for investigational allergy immunotherapy tablet
28 MAR 2013 The US FDA has accepted Merck’s biologics license application (BLA) for an investigational allergy immunotherapy tablet (AIT), Timothy grass pollen (Phleum pratense). The a…